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Abstract
Background: Pluripotent stem cells produce tissue-specific lineages through programmed acquisition of sequential gene
expression patterns that function as a blueprint for organ formation. As embryonic stem cells respond concomitantly to
diverse signaling pathways during differentiation, extraction of a pro-cardiogenic network would offer a roadmap to
streamline cardiac progenitor output.
Methods and Results: To resolve gene ontology priorities within precursor transcriptomes, cardiogenic subpopulations
were here generated according to either growth factor guidance or stage-specific biomarker sorting. Innate expression
profiles were independently delineated through unbiased systems biology mapping, and cross-referenced to filter
transcriptional noise unmasking a conserved progenitor motif (55 up- and 233 down-regulated genes). The streamlined
pool of 288 genes organized into a core biological network that prioritized the ‘‘Cardiovascular Development’’ function.
Recursive in silico deconvolution of the cardiogenic neighborhood and associated canonical signaling pathways identified a
combination of integrated axes, CXCR4/SDF-1, Flk-1/VEGF and BMP2r/BMP2, predicted to synchronize cardiac specification.
In vitro targeting of the resolved triad in embryoid bodies accelerated expression of Nkx2.5, Mef2C and cardiac-MHC,
enhanced beating activity, and augmented cardiogenic yield.
Conclusions: Transcriptome-wide dissection of a conserved progenitor profile thus revealed functional highways that
coordinate cardiogenic maturation from a pluripotent ground state. Validating the bioinformatics algorithm established a
strategy to rationally modulate cell fate, and optimize stem cell-derived cardiogenesis.
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Introduction
Pluripotent stem cells provide regenerative medicine with the
broadest repertoire of developmental programs [1–7]. Diversity of
stem cell derived cytotypes, each with discrete conditions
underlying lineage differentiation, necessitates targeted strategies
to harness tissue-specific progeny [8–13]. During differentiation of
pluripotent stem cells, cardiac progenitors are embedded within
heterogeneous populations of non-cardiac phenotypes [14–21].
Unsynchronized maturation of progeny, diverse patterns of
biomarker expression, and variable exposure to growth factors
or cytokine gradients confound the identification of a core
transcriptional motif that governs cardiogenesis [22–26].
Mapping the cardiogenic blueprint, innate to pre-cardiac
mesoderm, would offer a strategy to optimize cardiac lineage
procurement from embryonic stem cells (ESCs). As an initial step,
exposure of pluripotent ESCs to cardiopoietic factors was found to
enrich genomic programs towards cardiac lineage commitment
[27]. Characterization of cardiogenic progeny, derived via guided
differentiation of the mesoderm through endodermal cues,
extracted an ontological infrastructure that encompassed sarcomer-
ogenesis, excitation-contraction coupling, and calcium handling
suggesting a dynamic transcriptome that secures cardiogenesis [16].
In fact, a separate high-throughput bioinformatics approach, based
on a distinctivecellsurface biomarkersignatureduringearly cardiac
differentiation, sorted cardiogenic precursors out of a pool of
unconstrained pluripotent stem cell progeny [28]. The cardiac
predisposition originating from these independent progenitor
subpopulations implies a conserved cardiogenic gene network
disguised by stochastic transcriptional noise within the pleiotropic
stem cell background [29,30].
To distill essential signaling components and prioritize pathways
of cardiac differentiation across distinct cytotype fates would
require an integrated, systems-based approach [31,32]. Unbiased
functional resolution of genome-wide transcriptional profiles may,
to this end, provide a rational basis for targeted optimization of
phenotypic output [33–35]. Here, cross-referencing a comprehen-
sive pool of genome-wide transcripts within distinct progenitor
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secured cardiogenic commitment. Comparison of growth factor-
guided and biomarker-sorted cardiogenic subpopulations filtered
non-cardiac transcriptional noise to unmask a pre-cardiac
blueprint that contained a core cardiac network with complemen-
tary hubs predicted to drive cardiogenesis. Targeting the
prioritized collective axis of SDF-1/CXCR4, VEGF/Flk-1 and
BMP2/BMPr was sufficient to augment in silico-postulated cardiac
differentiation, and accelerate in vitro cardiogenesis. This strategy
establishes a novel paradigm in which comparative refinement
prioritized conserved tissue-specific targets across progenitor
profiles, streamlining production of stem cell-derived pedigrees.
Results
Heterogeneity of pre-cardiac transciptome masks early
lineage-specific pathways
Pluripotent stem cells within differentiating embryoid bodies,
primed by the growth factor TNF-a for cardiogenic guidance
[11,27], produced enrichment in cardiac tissue (Figure 1). Within
the heterogeneous cellular mixture (Figure 1A, left), guided pre-
cardiac cells were characterized by an intermediate phenotype
that included nuclear internalization of cardiac transcription
factors (Mef2C, Nkx2.5) yet absence of cytoplasmic contractile
proteins (Figure 1A, middle). Progenitor cells were enriched from
day 7 beating embryoid bodies according to density gradient
separation, and by day 12 evolved into differentiated cardiomy-
ocytes that displayed co-staining of nuclear Mef2C with
cytoplasmic a-actinin (Figure 1A, right). Genome-wide microarray
analysis identified a cardiopoietic profile consisting of 16,721
differentially expressed transcripts (4,163 up- and 12,558 down-
regulated) that distinguished the pro-cardiac cytotype from the
pluripotent ground state (Figure 1B). Independently, quantitative
RT-PCR of selected transcripts (Oct4, Sox2, CXCR4, Flk-1, Gata4,
Nkx2.5, Mef2C) confirmed cardiogenic commitment within the
progenitor subpopulation (Figure 1C). Ingenuity function analysis
of the 4,163 progenitor-specific up-regulated transcripts, however,
revealed broad ontologies, such as ‘‘Cellular Growth and
Proliferation’’, ‘‘Hematologic Disease’’ and ‘‘Oncogenicity’’,
without prioritization of lineage-specific pathways (Figure 1D).
Transition to the more mature cardiomyocytes, which encom-
passed 4,515 differentially upregulated transcripts, was necessary
to demonstrate cardiogenic pathways (Figure 1E). Thus, due to
transcriptional noise of early stage progenitors, prioritization of
functional signaling pathways was unable a priori to resolve the
predicted cardiac phenotype.
Biomarker selected progenitors segregate a lineage-
specific transcriptome
A dual biomarker signature extracts a stage-specific cytotype
according to cell surface expression of CXCR4/Flk-1 after 5 days
of spontaneous differentiation from pluripotent stem cells [28].
Compared to CXCR4
2/Flk-1
2 counterparts lacking the ability to
differentiate into cardiomyocytes, CXCR4
+/Flk-1
+ progenitors
here expressed nuclear Mef2C at day 6 (Figure 2A, left) and co-
expressed cardiomyocyte specific nuclear Mef2C and sarcomeric
a-actinin at day 9 (Figure 2A, right). Genome-wide microarray





2 subpopulations at day 5, yet the
divergent gene expression profile represented more than 700
unique transcripts (Figure 2B). Validation of the microarray-
predicted pro-cardiac predisposition in the CXCR4
+/Flk-1
+
subpopulation was obtained via a panel of pluripotency (Oct4,
Sox2), endoderm (Sox17), mesoderm (Goosecoid, Lhx1), and cardiac-
specific markers (Gata4, Nkx2.5, Mef2C, Myocd; Figure 2C).
Ingenuity functional analysis of the 294 up-regulated and 440





2 subpopulations identified an overt onto-
logic prioritization of ‘‘Cardiovascular Development’’
(p=5.52610
24; Figure 2D). Thus, a biomarker-selected subpop-
ulation from spontaneously differentiated pluripotent stem cells
identifies a pool of genes that non-stochastically integrate into a
blueprint providing instructions for cardiac lineage-specification.
Conserved gene expression profile extracts a cardiogenic
network
Based on two independent transcriptome profiles of growth
factor guided (Figure 1) or stage-specific biomarker selected
(Figure 2) progenitors, unbiased bioinformatic cross-referencing
identified clusters of genes conserved during cardiogenic specifi-
cation. Comparative analysis of progenitor profiles distilled a
common roster of pro-cardiogenic genes using Venn diagrams
(Figure 3A), with 55 up-regulated and 233 down-regulated
transcripts relative to non-cardiogenic populations. Ingenuity
function analysis further characterized the overrepresented
developmental ontologies and signaling pathways encoded by this
conserved gene expression profile, with an overall prioritization of
‘‘Cardiovascular Development’’ (Figure 3B). Restriction of pro-
genitor gene expression profiles according to conserved identities
streamlined the list of candidate genes by more than 70%,
and strengthened the prioritization of cardiac developmental
pathways.
Prioritized hubs for cardiogenic induction
Biological networks exhibit quantifiable architectural charac-
teristics [36]. Here, the conserved transcriptome formed an
integrated cardiogenic network (Figure 4A) that exhibited
mathematical property distributions attributed to scale-free
(Figure 4B), and hierarchical (Figure 4C) network topologies,
consistent with non-stochastic physiological systems. Ingenuity
Pathway Analysis predicted and quantified preferential signaling
pathways within this progenitor network. BMP2 signaling was
overall prioritized (p=1.47610
23), followed by regulation of
innate immunity (p=6.61610
22), retinoic acid receptor activation
(p=1.34610
22), CXCR4-dependent chemokine signaling
(p=2.09610
22), and TGFb1 signaling (p=2.31610
22;
Figure 4D). Based on this conserved cardiogenic network, an
unbiased recursive bioinformatics algorithm prioritized a neigh-
borhood of genes independently associated with cardiovascular
developmental ontologies and centered on highly connected hubs,
including BMP2, PI3K, STAT3, P38MAPK, Akt, ERK, VEGF,
Jun and Rb1 (Figure 5A). Transcripts upregulated and related to
the hubs, namely BMP2, CXCR4, CXCR7, EFNB2, Flk-1,
HAS2, Sox7, CYR61, VAV3 and Jun, were validated in each
progenitor population, and independently linked to cardiovascular
specification or cardiac pathophenotypes based on the Mouse
Genome Informatics Database. Furthermore, this empirical gene
cluster was separately identified by Ingenuity as the predominant
sub-network of the integrated transcriptome, with an overall
signaling prioritization related to ‘‘Cardiovascular Development’’
(Figure 5A). Hub inter-relationships were quantified based on local
module connectivity, and calculated as the total number of direct
gene connections representing a weighted importance of each
signaling relay in cardiac differentiation pathways (see Materials
and Methods). In this way, an order of hub connectivity was
extracted with nine hubs providing the integrated scaffold of the
cardiac neighborhood (Figure 5B). Hub interactions were mapped
for each of the upregulated transcripts, and revealed that
Specified Cardiac Progenitors
PLoS ONE | www.plosone.org 2 April 2010 | Volume 5 | Issue 4 | e9943Figure 1. Heterogeneity of a primitive cardiac progenitor transcriptome precludes prioritization of cardiac pathways. (A) TNF-a
guided differentiation of pluripotent embryonic stem cells (ES) facilitated generation of cardiopoietic (CP) progenitors, marked by nuclear
internalization of Mef2C. Differentiated cardiomyocytes (CM) co-expressed nuclear Mef2C and sarcomeric a-actinin. (B) The cardiopoietic
transcriptional profile encompassed 16,721 genes differentially expressed in CP versus ES. The signature CP transcriptome profile was defined herea s
a composite of significantly changed gene levels ($20%, p,0.05) compared to the ES source. Blue, down-regulated genes; Red, up-regulated genes;
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to collectively hit all nine hubs of the network (Figure 5C). Thus,
an integrated network, conserved across two cardiogenic cyto-
types, and an unbiased systems biology approach streamlined the
minimal triad of ligand/receptor pairs hypothesized in silico to
simultaneously activate pro-cardiac pathways (Figure 5D).
Targeted enhancement with SDF-1/VEGF/BMP2
promotes cardiogenic output from pluripotent stem cells
Derived from embryoid bodies, fluorescence activated flow-
sorting analysis of individual cells revealed a baseline profile of
persistently low levels of cardiac-myosin heavy chain (MHC)
expression during the first 5 days of progenitor differentiation
(3.5% positive cells at day 3.5), followed by an induction at day 7
(,26% positive cells) that reached a plateau (,50% positive cells)
at day 8 (Figure 6A). Treatment with SDF-1, VEGF and BMP2
induced significant enrichment (50% increase over baseline at days
6.5 and 7.5) in cardiac-MHC expressing cells in treated versus
untreated embryoid bodies (Figure 6A). Moreover, targeted
treatment with SDF-1, VEGF and BMP2 increased embryoid
bodies beating activity as early as day 6 from 5% to 30%. The
cardiogenic benefit was sustained throughout differentiation, with
targeted treatment maximizing beating activity by day 8.
Furthermore, treatment of day 5 embryoid bodies led to significant
down-regulation of pluripotent (Oct4) and early pre-cardiac
mesoderm (Mesp1) markers within 12 h of treatment, compared
with untreated controls (Figure 6B, left). The treatment effect was
followed by a significant induction in gene expression of cardiac
transcription factors (Nkx2.5, Mef2C) and contractile proteins
(cardiac-MHC), not observed in the untreated counterparts
(Figure 6B, right). In treated progeny, RT-PCR demonstrated
increased cardiac markers, such that expression kinetics coincided
with beating activity. Therefore, functional activity, native gene
expression, and induction of a cardiac reporter system corrobo-
rated the cardiogenic influence of applied treatment as predicted in
silico.
Individual embryoid bodies treated with SDF-1, VEGF and
BMP2 consistently demonstrated no observable difference com-
Yellow, non-changing genes. (C) RT-PCR confirmed microarray predicted trends for selected transcripts. Blue, down-regulated genes; Red, up-
regulated genes. (D) Ingenuity functional analysis prioritized generic developmental categories within the rich transcriptional profile of cardiopoietic
(CP) cells. (E) Upper – Differentiated cardiomyocytes (CM) were distinguished from CP counterparts by 4,515 differentially expressed genes. Blue,
down-regulated genes; Red, up-regulated genes; Yellow, non-changing genes. Lower – Within CM-specific transcripts, ‘‘Cardiovascular Development’’
(p=8.56610
28, highlighted in red in histogram) was prioritized among all other upregulated developmental programs.
doi:10.1371/journal.pone.0009943.g001
Figure 2. CXCR4/Flk-1 biomarker signature enriches for cardiac progenitors. (A) Sorted double positive (+,+) and double negative (2,2)
cells were tracked for phenotypic differentiation in culture. Double positive cells displayed Mef2C nuclear localization at day 6 and expressed
sarcomeric a-actinin at day 9 (lower panels). Double negative cells did not express markers of cardiac differentiation (upper panels). (B) Volcano plot
analysis of gene expression data from double positive cardiac progenitors revealed significant differences compared to day 5 double negative
cohorts. Red dots, differentially up-regulated transcripts ($20% fold change, p,0.05); blue dots, down-regulated transcripts ($20% fold change,
p,0.05); yellow dots, shared transcriptome at day 5 embryoid bodies, independent of CXCR4/Flk-1 biomarker expression. (C) RT-PCR confirmed
microarray predicted gene expression trends for selected transcripts. Blue, down-regulated, Red, up-regulated. (D) Ingenuity functional analysis of the
double positive progenitor transcriptome revealed an ontologic prioritization (1) of ‘‘Cardiovascular Development’’ (p=5.52610
24), compared to
other physiological systems (2–6).
doi:10.1371/journal.pone.0009943.g002
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PLoS ONE | www.plosone.org 4 April 2010 | Volume 5 | Issue 4 | e9943Figure 3. Transcriptome intersection of cardiopoietic and double positive progenitors uncovers a conserved cardiac signature. (A)
Upper – Venn diagrams revealed a common transcriptome pool of 55 up-regulated and 233 down-regulated genes that represented similarly
Specified Cardiac Progenitors
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ation, yet as early as day 6 exhibited an increase in cardiac-MHC
promoter expression, with no corresponding LacZ reporter
staining observed in the untreated control populations (Figure 7).
Areas positive for cardiac-MHC/LacZ expanded on day 7, and
embryoid bodies demonstrated .50% of cell mass expressing
cardiac-MHC by day 8. Interestingly, embryoid bodies treated
with the SDF-1, VEGF and BMP2 cocktail reliably produced a
distinctive LacZ expression pattern with a ring-like shape or a
linear alignment of a-MHC positive cytotypes in contrast to the
random distribution of cardiogenic progeny in untreated controls.
Furthermore, quantified increases in contractile foci were observed
in SDF-1/VEGF/BMP2-treated embryoid bodies compared with
untreated controls. Thus, targeted modulation of prioritized
cardiogenic hubs exerts a quantifiable biological output in
differentiating stem cells validating a rational approach to optimize
cardiogenic induction from a pluripotent source and suggesting a
strategy to position cardiac progenitors within tissue constructs
according to chemokine gradients.
Discussion
Heterogeneity of gene expression in differentiating pluripotent
stem cells obscures the resolution of fate-specific developmental
networks that initiate cardiac specification during embryonic
organogenesis [37–39]. Here, bioinformatic refinement of a
changing genes in cardiopoietic (CP) and double positive (+,+) cells. Lower – Volcano plot analysis of the double positive progenitor cell
transcriptome (grey), overlaid with up-regulated (red dots) and down-regulated (blue dots) transcripts shared with CP. (B) In silico gene ontology
analysis of the common progenitor transcriptome revealed persistent functional prioritization of ‘‘Cardiovascular Development’’. Developmental
categories are plotted according to a p-value score calculated to represent a weighted ontologic functional prioritization within the integrated 288
gene pool, i.e., p-value score = -log(p-value-Upregulated List) - (-log(p-value-Downregulated List). Red (positive y-axis) designates overall
upregulated developmental programs within the integrated transcriptome, while blue (negative y-axis) designates overall downregulated
developmental programs.
doi:10.1371/journal.pone.0009943.g003
Figure 4. Conserved gene expression between progenitor transcriptomes extracts a network with quantifiable topology. (A)
Ingenuity built an integrated cardiogenic scaffold of 363 molecules (i.e., network nodes) connecting the 288 progenitor shared genes and their direct,
database predicted biological partners. Cytoscape interaction analysis decoded 1801 direct molecular relationships (i.e., network edges). X-axis
represents the number of neighbors, k, for each network node. Y-axis, n(k), represents the number of nodes with k neighbors and follows a power-law
equation, with the majority of nodes having few connections and several highly connected nodes. The average calculated degree of the network, i.e.,
average number of neighbors for each gene (k) was 9.5. (B) The degree distribution, P(k), established a linear correlation (R=0.970) on the log-log
scale with the number of neighbors, k, a feature characteristic of scale-free networks. (C) The clustering coefficient, C(k), was calculated according to
the inset formula, and correlated (R=0.830) on a log-log scale with the number of neighbors, k. A linear logC(k) distribution denotes the hierarchical
nature of the network. (D) The prioritized canonical pathways within the integrated network included BMP2, CXCR4/chemokine and TGFb signaling.
doi:10.1371/journal.pone.0009943.g004
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stem cell-derived cardiac progenitors, sufficiently reduced plat-
form-specific background noise to extract a robust pro-cardiogenic
network from precursors captured en route to cardiomyocyte
differentiation. Restricting analysis to the common pool of
progenitor genes synchronized ‘‘Cardiovascular Development’’
within a streamlined ontological infrastructure, and revealed
identities of prioritized network hubs that promoted pluripotent
stem cell-derived cardiogenesis. Accordingly, targeted treatment
with SDF-1, VEGF, and BMP2 was designed to activate predicted
network hubs, a strategy that effectively accelerated cardiac
determination. In fact, this rationally designed therapy, uncovered
by genome-wide screening, demonstrated significant induction of
Nkx2.5, Mef2C, cardiac-MHC, and enhanced beating activity from
pluripotent progenitors. Thus, recursive bioinformatics analysis of
discrete stem cell-derived progeny fostered deconvolution of a
signature sub-network that contained ontologically aligned hubs
responsive to pro-cardiac modulation, establishing a tailored
approach to optimize cardiogenic yield from a pluripotent source.
Simultaneously active gene networks in differentiating stem cells
create dynamic heterogeneities that lead to a spectrum of cellular
phenotypes, a basis for transcriptional noise [29]. Heterogeneity
reflects metastable states of a slowly fluctuating transcriptome that
encodes distinct and reversible cytotypes which prime a pluripo-
tent background for single lineage commitment and govern the
stochastic process of cell fate decision [30]. In principle, signaling
stimuli applied to a dynamic transcriptome could shift develop-
mental equilibria towards progenitor states thereby increasing the
probability of cardiogenic specification versus alternative develop-
mental programs [30,40]. Partial modulation of necessary
Figure 5. Prioritization of network hubs for cardiogenic induction. (A) A neighborhood of genes, cross-referenced with the Mouse Genome
Informatics (MGI) knockout-based cardiac phenotype database, was independently established by Ingenuity as the most prioritized sub-network of
the integrated cardiogenic framework. Nodes in the network are pink (upregulated pro-cardiac genes) or yellow (database-predicted direct
interacting genes). Hubs are defined as highly connected nodes (genes) outlined in the network by colored circles. (B) Local module connectivity was
defined for each of the network hubs as the total number of node connections they establish. (C) A relative pathway connectivity score (red, line
graph) was calculated for the upregulated pro-cardiac genes, defined as the ratio of the number of hubs each cardiac gene is connected to over the
total number of hubs available in the sub-network. (D) The integrated signaling model predicts the behavior of the network in the context of a triple
treatment that would collectively target all integrating signaling highways. Co-stimulation of the SDF-1/CXCR4, VEGF/Flk-1 and BMP2/BMP2r axes is
predicted to simultaneously activate all network hubs and empirical cardiac genes. Biological output will be quantified via nuclear transcription
factors (i.e., Mef2C) and reporter assays (cardiac-MHC–Lac Z) as surrogates for de facto cardiogenic specification.
doi:10.1371/journal.pone.0009943.g005
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plaque differentiation protocols based on random inclusion
criteria. An unbiased approach to reveal a comprehensive and
integrated strategy may thus offer a higher degree of reproduc-
ibility. Here, a cardiac specific gene regulatory network provided a
molecular fingerprint of mitotically active, yet lineage committed
cardiac progenitors, that facilitated selective targeting and clonal
expansion of a therapeutically relevant pro-cardiac population.
As developmental programs for multiple lineages are simulta-
neously activated in the differentiating embryoid body, a hetero-
geneous mixture of cytotypes emerges that confound cardiac
lineage-specific contributions [41–44]. Strategies to enrich cardiac
progenitors are thus required to harness the regenerative potential
of pro-cardiac progeny while eliminating the risks of uncontrolled
teratogenic expansion [8,13,24,41]. Our initial strategy of endo-
derm-based recombinant growth factor-guided stimulation of
embryonic stem cells extracted an intermediate population of
cardiopoietic progenitors that were enriched according to the
limitation of density gradients [27]. Genome-wide expression
analysis solved this pro-cardiac phenotype in relationship with bona
fide cardiomyocytes, and evidenced the underlying activated
pathways of pro-cardiac to cardiac determination [16]. Here, a
cardiopoietic transcriptional profile of 16,721 genes uniquely
identified the intermediate cardiac phenotype and offered the initial
blueprint for candidate gene discovery of progenitor specific
biomarkers. The inherent stochasticity associated with large pools
of genes was found to increase the transcriptional noise in
cardiopoietic progenitors, and preclude prioritization of signaling
axes for regulation of cardiogenic output. Only general develop-
mental categories, such as ‘‘Cell Growth and Proliferation’’, were
associated with this parental, density-enriched cardiopoietic popu-
lation that inevitably contained confounding cytotypes. A subse-
quent strategy capitalized on the uncovered cardiopoietic-specific
cell surface biomarkers and flow sorting strategies to enrich a
homogeneous population of CXCR4
+/Flk-1
+ double positive
cardiac progenitors [28]. Indeed, genome-wide analysis of this
synchronized clonal population revealed less variability than
cardiopoietic progenitors and a compact transcriptome of 734
genes that collectively encoded the required pathways for
cardiogenic specification. Cross-referencing gene expression profiles
Figure 6. Targeted treatment with SDF-1/VEGF/BMP2 increases cardiogenic yield. (A) a-MHC R1 embryonic stem cells were differentiated
by the hanging drop method. Baseline embryoid body (EB) beating activity (columns) and FACS-gal a-MHC positive cell embryoid body composition
(diamonds) were quantified (blue). Floating EBs (inset) transferred to gelatinized 6 well plates in the evening of day 4 were treated with SDF-1
(100 ng/mL), VEGF (10 ng/mL), and BMP2 (10 ng/mL) or differentiation media alone at Day 4.5. EBs were collected each day for FACS-gal analysis, RT-
PCR and X-gal staining. Beating activity was recorded daily for each treatment condition for ,300 EBs. Beating activity is represented by columns
(blue for baseline, red for treatment), % cardiac-MHC-Lac Z positive cells are represented by diamonds (blue, red respectively). (B) RT-PCR analysis for
selected pluripotency (Oct4), pre-cardiac mesoderm (Mesp1) and canonical cardiac (Nkx2.5, MEF2C, cardiac-MHC) transcripts. Red bars represent
treatment with SDF-1, VEGF and BMP2; blue bars represent the baseline, untreated condition.
doi:10.1371/journal.pone.0009943.g006
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phenotype further reduced transcriptional noise, and streamlined
288 conserved cardiogenic transcripts. Therefore, unbiased recur-
sive refinement of pro-cardiac transcriptional profiles restricts
genomic complexity from over 16,000 genes in cardiopoietic cells
to 734 genes in double positive progenitors, and ultimately 288
genes in the conserved transcriptome, while progressively increasing
pro-cardiovascular ontologic prioritization and unmasking poten-
tially necessary and sufficient hubs for cardiogenic activation.
The ability of two unique cellular subpopulations to acquire a
common cardiac endpoint implies requisition of core gene
networks that collectively guide a heterogeneous transcriptome
to engage fate-specific programs. Intersection of discrete tran-
scriptomes, from progenitors with a common fate, thus filtered
transcriptional noise and facilitated elucidation of persistent
molecular elements that comprise a stabilized transcriptome
essential for ultimate cardiogenic determination. Furthermore,
the conserved cardiac pedigree integrated and organized as a
network with quantifiable, biologically relevant properties [36].
This ontologic infrastructure delineated a cardiac neighborhood
encompassing up-regulated progenitor-specific genes with a pro-
cardiac phenotype, cardiovascular transcription factors, and
interconnecting hubs (SDF-1/CXCR4, VEGF/Flk-1, BMP2/
BMP2r) that are relays to major canonical signaling highways.
Thus, the distilled cardiac and vascular sub-network rationally
targeted pathways for enhancement of cardiovasculogenesis.
Network architecture deconvolution predicted the necessary
combination of signaling axes to stimulate prioritized hubs, and thus
activate in a targeted manner the preferential signaling highways for
cardiogenic specification. Bioinformatic network predictions were
validated when SDF-1/VEGF/BMP2-treated embryoid bodies
displayed precocious expression and sustained up-regulation of
cardiac transcription factors, beating activity and cardiac cell yield,
comparedtountreatedcontrols.Althoughstemcellcardiogenesishas
previously been enhanced with BMP2 [45,46] and VEGF [47,48],
stromalderivedstemcellfactor(SDF-1)hasyettobedemonstratedas
a pro-cardiogenic cytokine on pluripotent stem cells. In line with the
presentstudy,initialevidenceforaroleofSDF-1incardiogenesiswas
postulatedbytheobservedcardiacphenotypeinknockouttransgenic
strains [49], and by the established role of the CXCR4/SDF-1
signaling axis in cardiac regeneration after myocardial infarction
[50]. Furthermore, from pluripotent stem cells, pre-cardiac expres-
sion of the SDF-1 receptor CXCR4, in combination with Flk-1, has
demonstrated the ability to isolate cardiac precursors [28]. Although
notthefocusofthisinvitroanalysis,thebiologicalandpossibleclinical
significanceofSDF-1/CXCR4axisalone orcombinationwithother
soluble factors may provide a relevant target to not only promote
progenitor cell localization to the most appropriate niche environ-
ment but also significantly contribute to cardiac-specific differenti-
ation within the injured heart. Therefore, the bioinformatics
prediction of the unique integration of hubs encompassing SDF1/
CXCR4, VEGF/FLK-1, and BMP2/BMPr was grounded by
independent evidence, and was here demonstrated for the first time
as a potent signaling triad for enhanced cardiogenesis with potential
for translation into biomedical applications.
Embryoid body differentiation is a versatile model system to
dissect molecular mechanisms underlying cardiac fate decision
according to genomic, proteomic and/or metabolomic profiling
[16,51–53]. Successful translation of pluripotent stem cell technol-
ogy is contingent upon maximizing efficacy of lineage-specification
and minimizing risk of dysregulated oncogenic growth. The
therapeutic applicability of stem cell cardiogenic platforms is
critically dependent upon isolation of homogeneous populations
of cardiac progenitors to optimize myocardial repair and minimize
risks of in situ teratogenic transformation [15,27,54,55]. High
volume generation of stem cell-derived cardiomyocytes from in vitro
procurement has proven technically challenging, and subject to
random selection or inter-platform variability [4,8,12,41]. Decon-
voluting transcriptional hierarchy pertaining to cardiovascular
commitment, regardless of procurement strategy, is a feasible
approach as demonstrated herein to extract essential factors
required for cardiogenic differentiation from various stem cell
Figure 7. Augmentation of cardiac phenotype from pluripotent stem cells. X-gal stained embryoid bodies show early enrichment in
cardiac-MHC-LacZ expressing areas (blue staining) after 2 days of treatment (Day 6). On subsequent days, treated EBs consistently showed
upregulation in cardiac-MHC-LacZ expressing areas compared to untreated controls. Arrows indicated cardiac-MHC-LacZ expressing areas.
doi:10.1371/journal.pone.0009943.g007
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alignmentand prioritization ofpro-cardiacsignalingaxes, otherwise
masked by platform heterogeneity, and enabled targeted enhance-
ment. Overall, the present data demonstrate the biological
relevance of a conserved progenitor transcriptome as a dynamic
tool to prioritize essential developmental highways, and predict
molecular targets for rational control of organogenesis. Direct
targeting of hubs supporting cardiogenic specification, activates
preferential pathways and elicits a quantifiable biologic output in
embryoid bodies as evidenced by pro-cardiogenic synchronization
of progeny derived from pluripotent stem cells, advancing
traditional probabilistic methods into a novel deterministic strategy
for lineage induction.
Materials and Methods
Embryonic Stem Cell Cardiopoiesis
Murine embryonic stem cells, CGR8 and R1 [27,28], were
maintained in Glasgow’s Minimum Essential Medium (BioWhit-
taker-Cambrex) supplemented with pyruvate and L-glutamine
(Cellgro), non-essential amino acids (Mediatech), b-mercaptoeth-
anol (Sigma-Aldrich), 7.5% fetal calf serum (FCS) (Invitrogen) and
leukemia inhibitory factor (LIF) (ESGRO, Chemicon). Stem cells
were differentiated into embryoid bodies using the hanging-drop
method [56,57] in differentiation media supplemented with 20%
FCS and TNF-a (Invitrogen). Dual interface Percoll gradient
(Invitrogen) was used to separate sarcomere-rich, high density
cardiomyocytes from lower density, sarcomere-poor cardiopoietic
precursors from day 7 embryoid bodies that were guided towards
cardiogenic pathways according to TNF-a treatment [27].
Embryonic stem cell-derived progeny were fixed in 3% parafor-
maldehyde, permeabilized with 1% Triton X-100, and immuno-
stained with antibodies specific for Mef2C (1:400, Cell Signaling)
Nkx2.5 (1:150, Santa Cruz) and sarcomeric protein a-actinin
(1:1,000, Sigma-Aldrich) along with DAPI staining to visualize
nuclei [27]. Microscopy was performed using an LSM 510 laser
scanning confocal microscope (Carl Zeiss).
Flow Sorting for Biomarker Selected Cardiac Progenitors
Embryoid bodies after 5 days of differentiation were washed in
phosphate buffered saline (PBS) and dissociated using non-
enzymatic dissociation buffer (Invitrogen) for 10 min at 37uC.
Aggregates were triturated to obtain single cell suspensions. Derived
cells were spun down at 1,000 g for 5 min and resuspended in
propagation media (7.5% FCS) for 10 min to allow cells to recover.
Cells (2610
7) obtained from initial aggregates were collected and
immuno-stained for Flk-1 and CXCR4 biomarker expression
[19,28]. Cells were washed with PBS and resuspended in 1 ml
PBS which contained goat-CXCR4 antibody (1:150, Abcam),
placed on ice for 30 min incubation, followed by single wash with
10 ml PBS. Secondary anti-goat Alexa 488 (1:500, Molecular
Probes, Invitrogen) and phycoerythrin (PE)-conjugated primary
antibody for Flk-1 (1:200, BD Biosciences) were incubatedon ice for
30 minfollowedbysingle10 mlPBSwash.Cellswereisolatedusing
a FACS Aria SE flow cytometer (BD Biosciences). Alexa-488 was
excited with a 488 nm argon laser and detected through a 530/
30 nm bandpass filter. PE was excited with the 488 nm laser line
and detected through a 575/26 nm bandpass filter. Forward and
side scatter parameters were used to gate viable cell population
sorted into subpopulations.
RNA Isolation and Microarrays
Total RNA was isolated using the Micro-to-Midi Total RNA
Purification System (Invitrogen) or a Qiagen protocol using a
combination of gDNA Eliminator and RNeasy columns. Three
independent biological replicates were obtained for each condi-
tion, with a total of twelve biological samples for guided
cardiogenesis and six biological samples for biomarker selection.
Double stranded cDNA and labeled complementary cRNA were
obtained from isolated RNA with the latter hybridized to the
Mouse 430 2.0 GeneChip (Affymetrix). Gene Chips were scanned
with an argon-ion laser and data visualized using the Affymetrix
Microarray Suite 5.0 software.
Gene Expression Analysis
Microarray gene expression raw data were MIAME compliant,
and were deposited with the Gene Expression Omnibus database
(Guided cardiogenesis, Accession number: GSE6689; Biomarker
selection, Accession number: GSE20841). Analysis was performed
using the GeneSpring GX 7.3.1 software (Agilent Technologies).
All probe sets were filtered according to chip-specific background
noise, and genes expressing signals below threshold were removed
[34]. Quality filtering was performed according to an established
flag value, with values that are Present (P), Marginal (M) or Absent
(A) assigned to the marker. For guided cardiopoiesis, probe sets
from all conditions were normalized to gene expression levels at
pluripotent embryonic stem cell stage. For biomarker selection,





normalized to gene expression levels from CXCR4
2/Flk-1
2
hybridized arrays. To ensure that only genes with significant
transcriptional changes during cardiogenesis are selected, all probe
sets were filtered according to a flag value of Present or Marginal
in at least two out of three replicates for one experimental
condition. A filter on volcano plot was applied to identify
significant changes in gene expression (.1.2 fold, p,0.05) in
cardiopoietic progenitors compared to pluripotent embryonic stem
cells, and in CXCR4
+/Flk-1
+ cells compared to their double
negative counterparts.
Quantitative Gene Expression
cDNAwas synthesized fromtotal RNA samples using SuperScript
III First-Strand Synthesis System (Invitrogen). Real time PCR was
performed using a standard TaqMan PCR kit protocol on an
Applied Biosystems 7900HT Sequence Detection System (Applied
Biosystems) as described [16,19,28]. The 50 mlP C Rr e a c t i o n
mixture included 3 ml RT product, 25 ml TaqMAN Universal
Master Mix (Applied Biosystems), 19.5 ml RNase-free water and
2.5 ml TaqMan Gene Expression Assays (pre-designed, pre-opti-
mized probe and primer sets for each gene of interest). TaqMan
Gene Expression assays contain 2 unlabeled PCR primers (900 nM
each final concentration) and 1 FAM dye-labeled MGB probe
(250 nM final concentration). Reactions were incubated in 96-well
plates at 95uC for 10 min, followed by 40 cycles of 95uCf o r1 5sa n d
60uCfor1 min.Thethresholdcycle(Ct)wasdefinedasthefractional
cycle number at which fluorescence passes detection threshold. Ct
values were subsequently converted into relative fold changes
determined using the 2
2DDCT method, normalized to Gapdh (P/N
435,2662-0506003). Genes representative for pluripotency, gastru-
lation and cardiogenesis were included in the analysis, such as Oct4
(Mm00658129_gH), Sox2 (Mm00488369_s1), Cxcr4 (Mm01292123_
m1), Flk1 (Mm00440099_m1), Nkx2.5 (Mm00657783_m1), Gata4
(Mm00484689_m1), Lhx1 (Mm00521776_m1), Gsc (Mm00650681_
g1), Mef2c (Mm01340839_m1), Mesp1 (Mm00801883-g1), and a-
MHC (Mm00440347-gH).
Bioinformatic Function Analysis
Venn diagrams within GeneSpring were used to identify
overlapping transcripts with similar expression trends in both
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lists were generated - commonly upregulated and commonly
downregulated genes. Transcriptional profiles were functionally
analyzed using the Ingenuity Pathway Analysis Software IPA 7.0
(www.ingenuity.com). Intersecting gene lists consisting of concor-
dantly up- or down-regulated transcripts in progenitor populations
were subsequently analyzed. Based on the curated Ingenuity
Knowledge Database and using a right-tailed Fisher’s Exact Test,
overrepresented functions and pathways associated with intersect-
ing gene lists were identified and the significance of association (p-
value) was calculated based on the probability of pathway
assembly from a random set of genes of the same size as the
input list.
Network Modeling and Topology Analysis
Network building tools available within Ingenuity were
employed for bioinformatic modeling of networks [58,59]. The
Institute for Systems Biology Cytoscape 2.6.0 software (http://
www.cytoscape.org) was applied to Ingenuity-prioritized networks
to provide data regarding network topology in addition to
visualizing relationships [11]. Direct molecular interactions were
decoded using the Cytoscape visualization algorithm and basic
mathematical properties, such as degree distribution (Equation 1)
and clustering coefficient (Equation 2) were computed via Network
Analyzer 2.6.1 (Max Planck Institute, Computational Biology and
Applied Algorithmics, Saarbru ¨cken, Germany, http://med.bioinf.




Equation 1. Degree distribution P(k), where nk indicates number





Equation 2. Clustering coefficient Ci, where ni represents the
number of edges, or connections, adjacent to node (i), and ki the
number of nodes connected to node (i).
Hub Prioritization
Knockout phenotypes associated with conserved gene pools
were further investigated through bioinformatic mining of the
Ingenuity and Mouse Genome Informatics Databases (www.
informatics.jax.org). Within network clusters, inter-molecular
relationships were deconstructed and quantified based on local
module connectivity (n, n=number of direct gene connections) to
weigh hubs according to neighborhood prioritization. A relative
pathway connectivity score was used to rank upregulated pro-
cardiac transcripts according to the degree of connectivity via hubs





Equation 3. Relative pathway connectivity. A connectivity score,
Yi, was calculatedfor upregulated pro-cardiac transcripts, defined as
the ratio of total number of hubs connected to node i, xi, divided by
the total number of hubs available in the sub-network, N.
Cardiogenic Induction from Pluripotent Stem Cells
aMHC-lacZ R1 embryonic stem cells that express a cassette
containing the aMHC promoter upstream of b-galactosidase
cDNA were used to monitor acquired cardiogenesis, as previously
described [61,62]. Stem cells were maintained in Glasgow’s
Minimum Essential Medium (BioWhittaker-Cambrex) supple-
mented with pyruvate and L-glutamine (Cellgro), non-essential
amino acids (Mediatech), b-mercaptoethanol (Sigma-Aldrich),
15% fetal calf serum (FCS) (Invitrogen) and leukemia inhibitory
factor (LIF) (ESGRO, Chemicon). Embryoid bodies were
generated according to the hanging drop method with or without
treatment on day 4.5 with SDF-1 (100 ng/mL, provided by Dr.
Brian Volkman, Medical College of Wisconsin, Milwaukee,
Wisconsin [63], VEGF (10 ng/mL, R&D Systems; [46,64]) and
BMP2 (10 ng/mL, R&D Systems; [45,46]).
FACS Quantification of Cardiac-MHC Expressing Cells
FACS-Gal analysis was performed by FDG (fluorescein di-b-d-
galactopyranoside) loading and FACS analysis [65]. Each day,
embryoid bodies were collected, triturated with enzyme-free cell
dissociation buffer (Invitrogen), and resuspended in ice cold HBSS+
buffer (1x HBSS, 2% Fetal calf serum, 10 mM Hepes buffer
(pH 7.2), 1% Penicillin/Streptomycin) at 1610
6 cells/mL. Cellular
samples (100 mL) and equal volumes of FDG staining aliquots (1:10
dilution of the 20 mM FDG stock solution) were preheated at 37uC
for 10 min. FDG was loaded onto cells and the solution was
incubated at 37uC for 1 min before transfer into 15 mL Falcon
tubes containing 2 mL ice cold HBSS+ buffer. The incubation
continued on ice for 1.5 h allowing accumulation of the fluorescent
product (FITC). Samples were analyzed fresh with a Becton
Dickinson FACSscan using a 488 nm pre-excitation laser and a
fixed FITC detection filter. Forward and side scatter parameters
were used to gate the viable cell population. Unstained cells were
used as a negative control for FITC gating, and the percentage of
cardiac-MHC positive cells in each sample was determined.
X-gal Quantification of Cardiac-MHC Rich Areas
Embryoid bodies for each experimental condition were fixed
with glutaraldehyde (Sigma-Aldrich) for 30 min at room temper-
ature, followed by a 30 min wash with phosphate-based buffer and
overnight incubation at 37uC with X-gal staining solution
(Invitrogen), as previously described [62]. Embryoid body images
were captured with a ProgRes C3 camera-equipped Zeiss stereo
Discovery V20 microscope.
Statistics
Values are provided as mean + SE and Student’s t-tests with
95% confidence intervals were used to compare treatment groups.
p,0.05 was predetermined as significant.
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